Madelon Pijls-Johannesma

Summary

Affiliation: University Hospital Maastricht
Country: The Netherlands

Publications

  1. ncbi request reprint Health related quality of life assessment instruments: a prospective study on preference and acceptability among cancer patients referred for radiotherapy
    Madelon C G Pijls-Johannesma
    Department of Radiation Oncology Maastro Clinic, GROW, P O Box 5800, 6202 AZ Maastricht, The Netherlands
    Eur J Cancer 41:2250-6. 2005
  2. doi request reprint High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL
    Madelon Pijls-Johannesma
    Department of Radiation Oncology Maastro Clinic, Maastricht, The Netherlands
    Radiother Oncol 91:443-8. 2009
  3. doi request reprint Cost-effectiveness of particle therapy: current evidence and future needs
    Madelon Pijls-Johannesma
    Maastricht Radiation Oncology MAASTRO Clinic, University Medical Center, Maastricht, The Netherlands
    Radiother Oncol 89:127-34. 2008
  4. doi request reprint Particle therapy in lung cancer: where do we stand?
    Madelon Pijls-Johannesma
    Maastricht Radiation Oncology MAASTRO Clinic, Dr Tanslaan 12, 6229 ET Maastricht, The Netherlands
    Cancer Treat Rev 34:259-67. 2008
  5. ncbi request reprint Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials
    Madelon Pijls-Johannesma
    Maastro Clinic, University Hospital, Dr Tanslaan 12, 6229 ET Maastricht, The Netherlands
    Cancer Treat Rev 33:461-73. 2007
  6. ncbi request reprint [Protons and ions in the treatment of cancer; a systematic review of the literature]
    M C G Pijls-Johannesma
    Maastro Clinic, Dr Tanslaan 12, 6229 ET Maastricht
    Ned Tijdschr Geneeskd 150:2435-41. 2006
  7. doi request reprint A systematic methodology review of phase I radiation dose escalation trials
    Madelon Pijls-Johannesma
    Department of Radiation Oncology MAASTRO, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
    Radiother Oncol 95:135-41. 2010
  8. pmc Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review
    Madelon Pijls-Johannesma
    Maastricht Radiation Oncology MAASTRO Clinic, Dr Tanslaan 12, 6229 ET Maastricht, The Netherlands
    Oncologist 15:93-103. 2010
  9. doi request reprint The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research
    Janneke P C Grutters
    Department of Radiation Oncology MAASTRO, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P O Box 1588, 6201 BN Maastricht, The Netherlands
    Cancer Treat Rev 36:468-76. 2010
  10. doi request reprint Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer
    Erik Roelofs
    Department of Radiation Oncology MAASTRO, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center MUMC, Maastricht, The Netherlands
    J Thorac Oncol 7:165-76. 2012

Detail Information

Publications24

  1. ncbi request reprint Health related quality of life assessment instruments: a prospective study on preference and acceptability among cancer patients referred for radiotherapy
    Madelon C G Pijls-Johannesma
    Department of Radiation Oncology Maastro Clinic, GROW, P O Box 5800, 6202 AZ Maastricht, The Netherlands
    Eur J Cancer 41:2250-6. 2005
    ..Our results indicate that patients prefer answer categories that have descriptors in words or a narrow range of answer options, rather than non-described answer options or a broad range of answer options per question...
  2. doi request reprint High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL
    Madelon Pijls-Johannesma
    Department of Radiation Oncology Maastro Clinic, Maastricht, The Netherlands
    Radiother Oncol 91:443-8. 2009
    ..The purpose of this study was to investigate the evolution of quality of life (QoL) in patients with lung cancer, selected for curative radiotherapy (RT) or chemo-RT...
  3. doi request reprint Cost-effectiveness of particle therapy: current evidence and future needs
    Madelon Pijls-Johannesma
    Maastricht Radiation Oncology MAASTRO Clinic, University Medical Center, Maastricht, The Netherlands
    Radiother Oncol 89:127-34. 2008
    ..This paper aims to get more insight in the cost and cost-effectiveness of particle therapy and to discuss a future strategy that allows for critical assessment of this health technology...
  4. doi request reprint Particle therapy in lung cancer: where do we stand?
    Madelon Pijls-Johannesma
    Maastricht Radiation Oncology MAASTRO Clinic, Dr Tanslaan 12, 6229 ET Maastricht, The Netherlands
    Cancer Treat Rev 34:259-67. 2008
    ..From a theoretical point of view, charged particles should lead to superior results compared to photons. In this review, we searched for clinical evidence that protons or C-ions are really beneficial to patients with lung cancer...
  5. ncbi request reprint Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials
    Madelon Pijls-Johannesma
    Maastro Clinic, University Hospital, Dr Tanslaan 12, 6229 ET Maastricht, The Netherlands
    Cancer Treat Rev 33:461-73. 2007
    ..We undertook a systematic review and literature-based meta-analysis to determine whether the timing of chest radiotherapy may influence the survival of patients with limited stage small cell lung cancer (LS-SCLC)...
  6. ncbi request reprint [Protons and ions in the treatment of cancer; a systematic review of the literature]
    M C G Pijls-Johannesma
    Maastro Clinic, Dr Tanslaan 12, 6229 ET Maastricht
    Ned Tijdschr Geneeskd 150:2435-41. 2006
    ..To provide an overview of the present role of proton and ion therapy, also referred to as 'charged particle therapy', in the treatment of cancer...
  7. doi request reprint A systematic methodology review of phase I radiation dose escalation trials
    Madelon Pijls-Johannesma
    Department of Radiation Oncology MAASTRO, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
    Radiother Oncol 95:135-41. 2010
    ..The purpose of this review is to evaluate the methodology used in published phase I radiotherapy (RT) dose escalation trials. A specific emphasis was placed on the frequency of reporting late complications as endpoint...
  8. pmc Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review
    Madelon Pijls-Johannesma
    Maastricht Radiation Oncology MAASTRO Clinic, Dr Tanslaan 12, 6229 ET Maastricht, The Netherlands
    Oncologist 15:93-103. 2010
    ..In this review, we searched for clinical evidence to justify implementation of particle therapy as standard treatment in lung cancer...
  9. doi request reprint The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research
    Janneke P C Grutters
    Department of Radiation Oncology MAASTRO, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P O Box 1588, 6201 BN Maastricht, The Netherlands
    Cancer Treat Rev 36:468-76. 2010
    ..The present study focuses on stage I NSCLC, as no data is available for more advanced stages...
  10. doi request reprint Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer
    Erik Roelofs
    Department of Radiation Oncology MAASTRO, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center MUMC, Maastricht, The Netherlands
    J Thorac Oncol 7:165-76. 2012
    ..The hypothesis is that proton radiotherapy decreases the dose and the volume of irradiated normal tissues even when escalating to the maximum tolerable dose of one or more of the organs at risk (OAR)...
  11. doi request reprint Protons in head-and-neck cancer: bridging the gap of evidence
    Bram L T Ramaekers
    Department of Health Services Research, School for Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands
    Int J Radiat Oncol Biol Phys 85:1282-8. 2013
    ....
  12. doi request reprint How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons
    Andrea Peeters
    Maastricht Radiation Oncology MAASTRO Clinic, 6229 ET Maastricht, The Netherlands
    Radiother Oncol 95:45-53. 2010
    ..Particle therapy has potentially a better therapeutic ratio than photon therapy. However, investment costs are much higher. This study provides an estimation and comparison of the costs of these therapies...
  13. doi request reprint Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons
    Bram L T Ramaekers
    Department of Radiation Oncology MAASTRO, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
    Cancer Treat Rev 37:185-201. 2011
    ..To synthesize and compare available evidence considering the effectiveness of carbon-ion, proton and photon radiotherapy for head and neck cancer...
  14. doi request reprint The impact of late treatment-toxicity on generic health-related quality of life in head and neck cancer patients after radiotherapy
    Bram L T Ramaekers
    Department of Radiation Oncology MAASTRO, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
    Oral Oncol 47:768-74. 2011
    ..Xerostomia and dysphagia diminish generic HRQOL. Moreover dysphagia affects patients' HRQOL stronger than xerostomia...
  15. doi request reprint Health-related quality of life in patients surviving non-small cell lung cancer
    Janneke P C Grutters
    Department of Health Organization, Policy and Economics, Caphri Research Institute, Maastricht University, Maastricht, The Netherlands
    Thorax 65:903-7. 2010
    ..In this study, the EQ-5D was used to assess HRQoL in survivors of non-small cell lung cancer (NSCLC). The influence of tumour stage, adverse events, initial treatment and presence of recurrence was examined...
  16. pmc When to wait for more evidence? Real options analysis in proton therapy
    Janneke P C Grutters
    CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands
    Oncologist 16:1752-61. 2011
    ..Real options analysis, a technique originating from financial economics, assists in making this trade-off...
  17. doi request reprint Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis
    Janneke P C Grutters
    Department of Radiation Oncology Maastro Clinic, Maastricht University Medical Centre, 6200 MD Maastricht, The Netherlands
    Radiother Oncol 95:32-40. 2010
    ..To provide a comparison between radiotherapy with photons, protons and carbon-ions in the treatment of Non-Small-Cell Lung Cancer (NSCLC), performing a meta-analysis of observational studies...
  18. ncbi request reprint Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer
    Dirk De Ruysscher
    Department of Radiotherapy, University Hospital Maastricht, University Maastricht, Groel en Ontwikkeling, The Netherlands
    J Clin Oncol 24:1057-63. 2006
    ..To identify time factors for combined chemotherapy and radiotherapy predictive for long-term survival of patients with limited-disease small-cell lung cancer (LD-SCLC)...
  19. doi request reprint Charged particles in radiotherapy: a 5-year update of a systematic review
    Dirk De Ruysscher
    Department of Radiation Oncology, MAASTRO, Maastricht University Medical Center, The Netherlands
    Radiother Oncol 103:5-7. 2012
    ..In our view, the aim should be to build enough proton therapy facilities with interest in research to further improve the treatment and to run the needed clinical trials...
  20. doi request reprint Design of and technical challenges involved in a framework for multicentric radiotherapy treatment planning studies
    Erik Roelofs
    Department of Radiation Oncology MAASTRO, Maastricht University Medical Centre, The Netherlands
    Radiother Oncol 97:567-71. 2010
    ..The solutions that are given provide a useful guide for the set-up of future multicentric planning studies or public repositories of high quality data...
  21. ncbi request reprint Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma
    Ludy Lutgens
    Radiation Oncology, Maastro Clinic, Dr Tanslaan 12, 6229 ET Maastricht, Postbus 5800, Maastricht, Netherlands, 6202 AZ
    Cochrane Database Syst Rev 3:CD006377. 2010
    ....
  22. ncbi request reprint Psychometric properties of the revised Piper Fatigue Scale in Dutch cancer patients were satisfactory
    Pieter C Dagnelie
    Department of Epidemiology, NUTRIM, Maastricht University, P O Box 616, 6200 MD Maastricht, The Netherlands
    J Clin Epidemiol 59:642-9. 2006
    ..To examine the psychometric properties of the revised Piper Fatigue Scale (PFS) in Dutch cancer patients...
  23. ncbi request reprint Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side effect
    Veronique E M Mul
    Department of Radiation Oncology MAASTRO, GROW, University Hospital Maastricht, Maastricht, The Netherlands
    Radiother Oncol 82:5-9. 2007
    ..Exceptionally, BP may arise during RT. It is unclear which mechanism exactly triggers BP following megavoltage irradiation and whether there is a potential association with hormonal anticancer treatment...
  24. doi request reprint Determinants of overall quality of life in preterminal cancer patients
    Sandra Beijer
    Department of Epidemiology, NUTRIM, Maastricht University, Maastricht, The Netherlands
    Int J Cancer 123:232-5. 2008
    ..Our results clearly demonstrate that, in preterminal cancer patients, fatigue is a major contributor of overall QoL, corroborating reports in cancer patients in earlier disease stages...